Publications by authors named "Jan Podhorec"

Claim this Profile
E
Early changes of peripheral circulating immune subsets induced by PD-1 inhibitors in patients with advanced malignant melanoma and non-small cell lung cancer.
Simona Borilova, Peter Grell, Iveta Selingerova, Lenka Gescheidtova, Marie Mlnarikova, Jan Podhorec

BMC Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of AGR2 Gene-Specific Expression Patterns Associated with Epithelial-Mesenchymal Transition.
Andrea Martisova, Lucia Sommerova, Adam Krejci, Iveta Selingerova, Tamara Kolarova, Jan Podhorec

Int J Mol Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A large-scale assay library for targeted protein quantification in renal cell carcinoma tissues.
Petr Lapcik, Lucia Janacova, Pavla Bouchalova, David Potesil, Jan Podhorec

Proteomics· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transgelin Contributes to a Poor Response of Metastatic Renal Cell Carcinoma to Sunitinib Treatment.
Pavla Bouchalova, Jindrich Beranek, Petr Lapcik, David Potesil, Jan Podhorec

Biomedicines· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SWATH-MS Analysis of FFPE Tissues Identifies Stathmin as a Potential Marker of Endometrial Cancer in Patients Exposed to Tamoxifen.
Lucia Janacova, Jakub Faktor, Lenka Capkova, Vendula Paralova, Anna Pospisilova, Jan Podhorec

J Proteome Res· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AGR2 silencing contributes to metformin-dependent sensitization of colorectal cancer cells to chemotherapy.
Andrea Martisova, Lucia Sommerova, Katarina Kuricova, Jan Podhorec, Borivoj Vojtesek

Oncol Lett· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acetylsalicylic Acid and its Potential for Chemoprevention of Colorectal Carcinoma.
Ján Podhorec, Roman Hrstka, Ondřej Bílek, Štěpán Tuček, Jiří Navrátil

Klin Onkol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.
Philip J Coates, Rudolf Nenutil, Jitka Holcakova, Marta Nekulova, Jan Podhorec

Virchows Arch· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
ΔNp63 activates EGFR signaling to induce loss of adhesion in triple-negative basal-like breast cancer cells.
Jitka Holcakova, Marta Nekulova, Paulina Orzol, Rudolf Nenutil, Jan Podhorec

Breast Cancer Res Treat· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tamoxifen-Dependent Induction of AGR2 Is Associated with Increased Aggressiveness of Endometrial Cancer Cells.
Roman Hrstka, Jan Podhorec, Rudolf Nenutil, Lucia Sommerova, Joanna Obacz

Cancer Invest· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anterior gradient protein 3 is associated with less aggressive tumors and better outcome of breast cancer patients.
Joanna Obacz, Veronika Brychtova, Jan Podhorec, Pavel Fabian, Petr Dobes

Onco Targets Ther· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of mutation type on prognostic and predictive values of TP53 status in primary breast cancer patients.
Petr Dobes, Jan Podhorec, Oldrich Coufal, Andrea Jureckova, Katarina Petrakova

Oncol Rep· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis